Everything you need to know to prepare, format, and submit your manuscript to JIBDK. Please read these guidelines carefully before submission to ensure a smooth review process.
The Journal of Interdisciplinary Breakthrough & Discovery Knowledge (JIBDK) accepts original, unpublished research manuscripts from authors worldwide. All submissions must be written in English and must not be under consideration or published elsewhere. Simultaneous submission to other journals is strictly prohibited.
Format your manuscript per JIBDK guidelines. Ensure language is English and meets scope requirements.
Submit through the author portal. Upload manuscript, cover letter, and all required documents.
Preliminary editorial assessment within ~29 days for scope, formatting, and plagiarism screening.
Double-blind review by minimum two independent subject-matter experts (~90 days).
Editorial decision communicated by email. Accepted articles published with DOI within ~25 days.
JIBDK welcomes submissions in the following areas:
JIBDK accepts the following manuscript types. Please select the correct type during submission.
| Article Type | Word Limit | Abstract | Keywords | Max Refs | Max Figs |
|---|---|---|---|---|---|
| original Original Article | 3,000 – 5,000 | 250 words | 3–6 | 60 | 10 |
| review Review Article | 4,000 – 6,000 | 300 words | 5–10 | 120 | 15 |
| review Clinical Guidelines / Consensus Statement | 4,000 – 8,000 | 300 words | 5–8 | 100 | 15 |
| case Case Report | 1,500 – 2,000 | 200 words | 3–6 | 20 | 6 |
| case Case Series | 2,000 – 3,000 | 200 words | 3–6 | 30 | 8 |
| short Short Communication | Up to 1,500 | 150 words | 3–5 | 20 | 4 |
| short Images in Breast Health | Up to 500 | Not required | 3–5 | 5 | 4 |
| editorial Editorial | Up to 1,500 | Not required | — | 20 | 2 |
| letter Letter to Editor | Up to 500 | Not required | — | 10 | 1 |
All of the following must be submitted with your manuscript:
Addressed to the Editor-in-Chief. Include manuscript title, study importance, and originality confirmation.
Blinded manuscript (remove all author names and affiliations). MS Word .doc/.docx format.
Separate file with full title, running title, all author names, affiliations, and corresponding author details.
High-resolution figures (300 dpi, JPG/TIFF). Tables in editable Word format. Maximum 10 figures.
Ethics committee approval letter with reference number. Required for all human and animal studies.
Disclosure of any financial or personal relationships that could influence the work.
All funding sources and grant numbers must be declared.
| # | Section | Required | Notes |
|---|---|---|---|
| 1 | Introduction | Required | Background, rationale, and objectives. |
| 2 | Methods | Required | Study design, participants, interventions, statistical analysis. Include ethics approval reference. |
| 3 | Results | Required | Present data clearly without duplication in tables/figures. |
| 4 | Discussion | Required | Interpret results, compare with literature, address limitations. |
| 5 | Conclusion | Required | Brief, evidence-supported. No new data. |
| 6 | References | Required | Vancouver style, numbered consecutively. |
| 7 | Tables and Figures | If applicable | Numbered consecutively with descriptive captions. |
| 8 | Acknowledgements | If applicable | Technical assistance, non-author contributions. |
| 9 | Author Contributions | Required | Use CRediT taxonomy. |
| 10 | Conflict of Interest | Required | State "None declared" if no conflicts. |
| 11 | Funding | Required | All funding sources and grant numbers. |
Authors must follow applicable reporting guidelines. Select the guideline relevant to your study design:
All studies involving humans must report the ethics committee or IRB approval name and reference number in the Methods section.
Written informed consent must be obtained from all participants or legal guardians. Consent for publication of identifiable images or case reports is mandatory.
All financial, personal, or professional relationships that could influence the work must be disclosed. State "None declared" if no conflicts exist.
All funding sources, including grant reference numbers and funding agencies, must be listed in the Acknowledgements section.
Each author's contribution must be specified using the CRediT taxonomy. All authors must meet ICMJE authorship criteria.
Authors must disclose any use of AI writing tools (e.g., ChatGPT) in manuscript preparation. AI tools cannot be listed as authors.
Research involving animals must follow ARRIVE guidelines and report IACUC or equivalent ethical approval.
Clinical trials must be registered in a recognised registry before participant enrolment. The registration number must be included in the Methods section and the manuscript title page.
Plagiarism screening is mandatory for all submissions using Turnitin.
Plagiarism screening is mandatory for all submitted manuscripts. Self-plagiarism (duplicate publication) is treated the same as plagiarism.
Reviewers and authors remain anonymous to each other throughout the process. The editorial board's decision is final.
JIBDK is a fully open access journal. All published articles are immediately and permanently freely available to read, download, and share without any subscription barrier.
Authors retain copyright of their published work. Articles are published under the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Each published article receives a permanent Digital Object Identifier (DOI) via CrossRef, providing a permanent citation link and ensuring long-term discoverability.
All published articles are archived in institutional repositories, digital archives, and indexing platforms to ensure long-term preservation and accessibility.
Use this checklist to confirm your submission is complete before uploading.
You have read the guidelines. Now take the next step and submit your work to JIBDK.